Department of Cancer Biology, University of Kansas Medical Center, Kansas, KS, USA.
Department of Oral Radiation Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Oncogene. 2021 Aug;40(31):5013-5025. doi: 10.1038/s41388-021-01921-3. Epub 2021 Jun 28.
Accumulation of mutant p53 (mutp53) is crucial for its oncogenic gain of function activity. DNAJA1, a member of J-domain containing proteins or heat shock protein 40, is shown to prevent unfolded mutp53 from proteasomal degradation. However, the biological function of DNAJA1 remains largely unknown. Here we show that DNAJA1 promotes tumor metastasis by accumulating unfolded mutp53. Levels of DNAJA1 in head and neck squamous cell carcinoma (HNSCC) tissues were higher than those in normal tissues. Knockdown of DNAJA1 in HNSCC cell lines carrying unfolded mutp53 significantly decreased the levels of mutp53, filopodia/lamellipodia formation, migratory potential, and active forms of CDC42/RAC1, which were not observed in HNSCC cells with DNA contact mutp53, wild-type p53, or p53 null. Such mutp53-dependent functions of DNAJA1 were supported by the observation that DNAJA1 selectively bound to unfolded mutp53. Moreover, DNAJA1 knockdown in HNSCC cells carrying unfolded mutp53 inhibited primary tumor growth and metastases to the lymph nodes and lungs. Our study suggests that DNAJA1 promotes HNSCC metastasis mainly in a manner dependent on mutp53 status, suggesting DNAJA1 as a potential therapeutic target for HNSCC harboring unfolded mutp53.
突变型 p53(mutp53)的积累对于其致癌获得功能活性至关重要。DNAJA1 是 J 结构域包含蛋白或热休克蛋白 40 的成员,据显示可防止未折叠 mutp53 被蛋白酶体降解。然而,DNAJA1 的生物学功能在很大程度上仍不清楚。在这里,我们表明 DNAJA1 通过积累未折叠的 mutp53 促进肿瘤转移。头颈鳞状细胞癌(HNSCC)组织中 DNAJA1 的水平高于正常组织。在携带未折叠 mutp53 的 HNSCC 细胞系中敲低 DNAJA1 可显著降低 mutp53、片状伪足/片状伪足形成、迁移潜能和 CDC42/RAC1 的活性形式的水平,而在具有 DNA 接触 mutp53、野生型 p53 或 p53 缺失的 HNSCC 细胞中未观察到这些水平。这种依赖于 mutp53 的 DNAJA1 功能得到了以下观察结果的支持:DNAJA1 选择性地与未折叠 mutp53 结合。此外,在携带未折叠 mutp53 的 HNSCC 细胞中敲低 DNAJA1 可抑制原发性肿瘤生长和淋巴结和肺部转移。我们的研究表明,DNAJA1 主要通过依赖 mutp53 状态的方式促进 HNSCC 转移,这表明 DNAJA1 可作为携带未折叠 mutp53 的 HNSCC 的潜在治疗靶点。